STC2 and metabolic dysfunction-associated steatotic liver disease: Patil et al. (2023) found that CA-induced AhR-mediated STC2 induction can attenuate fatty liver degeneration, inflammation and liver injury in Non-Alcoholic Fatty Liver Disease (NAFLD) [29].